|
|
| MRD / Regn No. |
: 20260000378 |
Date |
: 08/07/2026 |
| Patient Name |
: Soumen Saha |
Age & Gender |
: 52 Yrs. / Male |
| Contact No. |
: 9734995105 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NKA |
Referred By |
: |
| |
|
|
Subjective |
: |
DM FOR 25 YEARS,SHOULDER PAIN
|
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM,INCREASED FIB 4 SCORE,A2G2 DKD,ADHESIVE CAPSULITIS,S2F0 MASLD |
|
Plan |
: |
INCREASE INSULIN TO 28-0-22 UNITS,INCREASE SEMAGLUTIDE 0.5 MG,SEE ME IN 2 WEEKS |
|
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES |
SQ |
28-0-22 UNITS |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
2 |
TABLET DAPAGLIFLOZIN 10 MG
UDAPA
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTION. INFORM IF THERE IS DYSURIA OR GENITAL ITCHING | |
|
3 |
ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE FATIGUE AND MUSCLE PAIN | |
|
4 |
TABLET IMEGLIMIN SR 1000 MG
IMEGLYN SR
Medicine For GLUCOSE CONTROL |
PO |
1-0-1 |
BEFORE FOOD
|
TILL NEXT VISIT |
|
|
5 |
INJECTION SEMAGLUTIDE 0.5 MG
SEMALIX 0.5
Medicine For DIABETES OBESITY HEART KIDNEY PROTECTION |
SQ |
EVERY WEEK |
AS DIRECTED NO RELATION TO FOOD
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA CONSTIPATION OR VISUAL DISTURBANCE | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 22/Jul/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP SMBG |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription |
Powered By:  |